netarsudil , CAS No.1254032-66-0, Inhibitor of Rho associated coiled-coil containing protein kinase 1;Inhibitor of Rho associated coiled-coil containing protein kinase 2

Item Number
N612224
Grouped product items
SKUSizeAvailabilityPrice Qty
N612224-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,000.90
N612224-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,400.90

Basic Description

SynonymsNetarsudil | NETARSUDIL [MI] | UNII-W6I5QDT7QI | NETARSUDIL [WHO-DD] | SCHEMBL16036278 | BDBM50546247 | Q27292390 | Benzoic acid, 2,4-dimethyl-, (4-((1S)-1-(aminomethyl)-2-(6-isoquinolinylamino)-2-oxoethyl)phenyl)methyl ester | [4-[(2S)-3-amino-1-(isoquin
Specifications & PurityMoligand™
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of Rho associated coiled-coil containing protein kinase 1;Inhibitor of Rho associated coiled-coil containing protein kinase 2

Associated Targets(Human)

ROCK2 Tclin Rho-associated protein kinase 2 (3 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ROCK1 Tclin Rho-associated protein kinase 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ROCK1 Tclin Rho-associated protein kinase 1 (4723 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ROCK2 Tclin Rho-associated protein kinase 2 (6206 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name [4-[(2S)-3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl]phenyl]methyl 2,4-dimethylbenzoate
INCHI InChI=1S/C28H27N3O3/c1-18-3-10-25(19(2)13-18)28(33)34-17-20-4-6-21(7-5-20)26(15-29)27(32)31-24-9-8-23-16-30-12-11-22(23)14-24/h3-14,16,26H,15,17,29H2,1-2H3,(H,31,32)/t26-/m1/s1
InChi Key OURRXQUGYQRVML-AREMUKBSSA-N
Canonical SMILES CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)C(CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C
Isomeric SMILES CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)[C@@H](CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C
Alternate CAS 1254032-66-0
PubChem CID 66599893
MeSH Entry Terms AR-13324;netarsudil

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Sturdivant JM, Royalty SM, Lin CW, Moore LA, Yingling JD, Laethem CL, Sherman B, Heintzelman GR, Kopczynski CC, deLong MA.  (2016)  Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma..  Bioorg Med Chem Lett,  26  (10): (2475-80).  [PMID:27072905] [10.1021/op500134e]
2. Ren R, Li G, Le TD, Kopczynski C, Stamer WD, Gong H.  (2016)  Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms..  Invest Ophthalmol Vis Sci,  57  (14): (6197-6209).  [PMID:27842161] [10.1021/op500134e]
3. Lin CW, Sherman B, Moore LA, Laethem CL, Lu DW, Pattabiraman PP, Rao PV, deLong MA, Kopczynski CC.  (2018)  Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma..  J Ocul Pharmacol Ther,  34  (1-2): (40-51).  [PMID:28609185] [10.1021/op500134e]
4. Serle JB, Katz LJ, McLaurin E, Heah T, Ramirez-Davis N, Usner DW, Novack GD, Kopczynski CC, ROCKET-1 and ROCKET-2 Study Groups.  (2018)  Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)..  Am J Ophthalmol,  186  (13): (116-127).  [PMID:29199013] [10.1021/op500134e]

Solution Calculators